48
Participants
Start Date
September 5, 2025
Primary Completion Date
October 31, 2027
Study Completion Date
June 30, 2028
ChAdOx1.tHIVconsv1
solution for injection one dose of 2.5 x 10\^10 vp/ml Arm B and Arm C
ChAdOx1.HIVconsv62
solution for injection one dose of 2.5 x 10\^10 vp/ml Arm B and Arm C
MVA.tHIVconsv4
suspension for injection two doses of 1 x 10\^8 vpu/ml Arm B and Arm C
GS-5423
Solution for infusion 2550 mg Arm A, Arm B and Arm C
GS-2872
Solution for infusion 850 mg Arm A, Arm B and Arm C
Treatment interruption induced viraemia
Participants pause ART before receiving vaccines and/or bNAbs Arm A and Arm C
NOT_YET_RECRUITING
Guys and St Thomas' NHS Trust, London
NOT_YET_RECRUITING
St Mary's Clinical Trial Unit, London
RECRUITING
Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Oxford
University of Oxford
OTHER